Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Renalytix plc
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
July 11, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
June 27, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
June 14, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
May 15, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
May 09, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Announces Financing with Expected Size of up to $4 Million
April 08, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
March 14, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024
February 15, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
January 10, 2024
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
November 14, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
November 07, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
October 06, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Reports Full Year Fiscal 2023 Results
September 28, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28
September 25, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer
September 07, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
August 03, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
July 21, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
July 07, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
July 03, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease
June 29, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
June 09, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
June 05, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
May 25, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
New Published Real-World Evidence Shows KidneyIntelX™ Utility
April 19, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting
April 12, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
March 30, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
March 22, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Renalytix announces a c.$20.3 million private placement
February 08, 2023
From
Renalytix plc
Via
GlobeNewswire
Tickers
RNLX
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.